FDA Drug Application (205879) for INVOKAMET XR by JANSSEN PHARMS

Back to FDA Applications sponsored by JANSSEN PHARMS

Application Number205879
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage50MG;500MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameINVOKAMET XR
Active IngredientCANAGLIFLOZIN; METFORMIN HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient CANAGLIFLOZIN3
List of drugs with Active Ingredient METFORMIN HYDROCHLORIDE32


Back to FDA Applications sponsored by JANSSEN PHARMS